NVO - Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand | Benzinga
The FDA on Thursday said it continues to investigate counterfeit Novo Nordisk A/S's (NYSE: NVO) Ozempic (semaglutide) injection of 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the diabetes drug.
FDA and Novo Nordisk are testing the seized products and do not yet have information about the drugs' identity, quality, or safety.
FDA said the needles from the samples were counterfeit. Accordingly, the sterility of the needles cannot be ...